XTANT MEDICAL HOLDINGS, INC. Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31)
XTANT MEDICAL HOLDINGS, INC. (XTNT) had Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) of $98.95 thousand as of 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValueCurrent · last filed 2013-05-10
- 2013-03-31: Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) $98.95K.
- 2012-12-31: Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) $91.74K.
- 2012-09-30: Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) $91.74K.
- 2012-06-30: Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) $91.74K.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) |
|---|---|
| 2013-03-31 | $98.95K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $91.74K 10-Q · filed 2013-05-10 |
| 2012-09-30 | $91.74K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $91.74K 10-Q · filed 2012-08-10 |
| 2011-12-31 | $450.17K 10-K · filed 2013-03-27 |
| 2011-09-30 | $450.17K 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |